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Abstract: Animal feeds may contain exogenous compounds that can induce toxicity when ruminants
ingest them. These toxins are secondary metabolites originating from various sources including plants,
bacteria, algae and fungi. Animal feed toxins are responsible for various animal poisonings which
negatively impact the livestock industry. Poisoning is more frequently reported in newly exposed,
naïve ruminants while ‘experienced’ ruminants are observed to better tolerate toxin-contaminated
feed. Ruminants can possess detoxification ability through rumen microorganisms with the rumen
microbiome able to adapt to utilise toxic secondary metabolites. The ability of rumen microorganisms
to metabolise these toxins has been used as a basis for the development of preventative probiotics to
confer resistance against the poisoning to naïve ruminants. In this review, detoxification of various
toxins, which include plant toxins, cyanobacteria toxins and plant-associated fungal mycotoxins,
by rumen microorganisms is discussed. The review will include clinical studies of the animal poisoning
caused by these toxins, the toxin mechanism of action, toxin degradation by rumen microorganisms,
reported and hypothesised detoxification mechanisms and identified toxin metabolites with their
toxicity compared to their parent toxin. This review highlights the commercial potential of rumen
inoculum derived probiotics as viable means of improving ruminant health and production.
Keywords: rumen microorganisms; plant toxins; probiotic; metabolism; degradation
Key Contribution: The review discusses various secondary metabolite toxins and up-to-date studies
on their detoxification by rumen microorganisms while highlighting the commercial potential of rumen
microorganisms to be used as probiotics against various plant toxins, cyanotoxins and mycotoxins.
1. Introduction
Common animal feeds including pasture grass, grains, crop residues, hay, silage and legumes
or even water sources may contain toxins that can cause poisoning when animals ingest them.
These toxins originate from secondary metabolites of plants, bacteria, algae or fungi and unlike
primary metabolites are not directly part of the normal growth, development or reproduction of
these organisms. Secondary metabolites by comparison are thought to protect against environmental
stresses and predators, providing an advantage to the organism producing them [1]. Chemically,
secondary metabolites comprise greater than 200,000 compounds which include compounds such as
alkaloids, saponins, phenolic acids, steroids and terpenoids [2,3]. Once ingested, certain toxic secondary
Toxins 2020, 12, 664; doi:10.3390/toxins12100664 www.mdpi.com/journal/toxins
Toxins 2020, 12, 664 2 of 37
metabolites can interrupt the metabolic pathway of the animal consumer inducing undesirable
biochemical and physiological changes in the cells, tissues and organs of the animal.
Toxic compounds can be commonly or seasonally found in ruminants’ feed or amongst pasture
grass naturally where ruminants can inadvertently consume them thus inducing poisoning symptoms.
Ruminants can develop adaptation mechanisms through rumen microorganisms to neutralise the
effects of toxic secondary metabolites. These toxins are not toxic against rumen microorganisms and
some can be used as energy sources for certain rumen microbial populations to adapt to toxins [4],
with the detoxification capacity relying heavily on the amount of toxin consumed [5]. Rumen microbial
populations are able to gradually change with prolonged, increasing exposure to toxins, thus allowing
gradual tolerance of the toxin in ruminants [6]. Degradation pathways of a toxin in most cases involve
a consortium of rumen microorganisms as the enzymes involved may not be present in a single rumen
bacterial species [7]. In the case where a single rumen bacterium is capable of toxin degradation,
there is a possibility of the presence of distinct microbial strains of the same species in the rumen that
contributes to the detoxification process [8]. However, toxin degradation by rumen microorganisms
does not always result in the detoxification of the toxins. For example, the mycotoxin zearalenone
(ZEA) was reported to be degraded by rumen microorganisms but their metabolites were suggested to
be more toxic compared to the parent toxin [9,10].
Various research studies have capitalised on the rumen’s capacity either through natural or
augmented microbial abundance in the development of preventative probiotics. Probiotics are
defined as live microorganisms which when administered in adequate amounts confer health benefits
to the host [11]. Such probiotics are able to produce nutrients, produce or stimulate enzymes,
provide competition with pathogens for adhesion sites, improve immune systems and metabolise or
detoxify toxins [12]. An effective probiotic is generally characterised as a strain that can be beneficial
to the host, has an appropriate count of viable cells, confers resistance to disease and toxins, yet is
non-pathogenic, non-toxic and able to survive and metabolise in the gut environment [13]. Probiotics can
be fed to naïve animals to confer resistance against the toxin thus allowing these animals to graze
pasture grass or feed that contain toxins without severe toxic effects. These probiotics can be derived
from either microorganisms in the environment which could degrade the toxins naturally or from
rumen microorganisms of animals that are resistant to the toxin.
Our understanding of animal poisoning by toxic plants has grown rapidly over the last decade,
along with new knowledge on the detoxification of plant toxins by adapted animals. However,
most studies only report on the detoxification ability of studied microorganisms without describing
the biochemical pathways for detoxification or their metabolites. This review mainly focuses on the
detoxification of toxins found in plant or cyanobacteria and plant-associated fungal mycotoxins by
rumen microorganisms and discusses the clinical studies of the toxicosis, toxin mechanism of action and
biochemistry behind detoxification metabolism (Table 1). The review will include toxin degradation
by rumen microorganisms producing reported and hypothesised less toxic or non-toxic metabolites
(Table 2). It also includes both reported and hypothesised detoxification mechanisms of various toxins
by rumen microorganisms, with particular emphasis on studies that have led or could potentially
lead to the development of protective microbial interventions with the capacity to degrade the toxin
for ruminants.
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Table 1. Summary of toxins and their effects on ruminants.
Toxin Name Toxin Source Effects on Ruminants
Mimosine Leucaena leucocephala Hair loss, goitre, poor cattle live-weightgain [14] and hypothyroidism [15]
4-N-acetyl-2,4-
diaminobutyric acid Acacia angustissima
Head pressing, grinding of teeth, foaming
at the mouth and jerking of the body [16]
β-N-oxalyl-l-α,β-
diaminopropionic acid Grass pea (Lathyrus sativus)
Lathyrism [17], induces oxidative stress
and excitotoxicity resulting in motor
neuron degeneration [18]
Indospicine Indigofera spp. (particularly I. linnaeiand I. spicata)
Hepatotoxic, teratogenic, loss in body
weight, embryo-lethal effects [19–22] and
reproductive losses [20,23,24]
Fluoroacetate
Naturally in over 40 plant species.
Also used as pesticide
(Compound 1080)
Death [25,26], acidosis,
hypocalcaemia and heart failure [27]
Pyrrolizidine alkaloids




Loss of appetite, diarrhoea and
depression [28]
Death [29–31] and megalocytosis [32]
Ingenol and ingenol esters Leafy spurge (Euphorbia esula L.) Aversion to plant [33], irritant andtumour promoter [34]
Microcystins and nodularin Cyanobacteria
Sudden death, reduced animal
performance [35] and potential to be
carcinogenic, hepatotoxic, immunotoxic,
neurotoxic and genotoxic [36–41]
Trichothecenes (Nivalenol,






rate, reproductive disorders, feed refusal,
vomiting [42], eukaryotic protein
synthesis inhibition [43] and generation of
free radicals [44]
Aflatoxin B1 Aspergillus fungi
Reduced animal health, performance,
reproduction [45], weight loss, liver
damage, decreased milk yield and
reduced feed utilisation efficiency [46]
Ochratoxin A Aspergillus and Penicillium fungi
Nephrotoxic, hepatotoxic, teratogenic,
carcinogenic [47–50], formation of
free radicals [51–54] and
fatal poisoning [55,56]
Fumonisins Fusarium verticillioides andFusarium proliferatum fungi
Liver, kidney damage [57–60] and
lymphocyte blastogenesis [57]
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Table 2. Rumen microorganisms and their role in toxin degradation to non-toxic metabolites.
Toxin Identified Rumen Microorganisms Role in Toxin Degradation
Mimosine Synergistes jonesii





diaminobutyric acid Bacteria not identified
Hydrolyses 4-N-acetyl-2,4-diaminobutyric




Diaminopropionic acid Firmicutes strain LPLR3; Klebsiellastrain LPSR1






Degradation pathway and metabolites
not identified [65,66]
Indospicine Bacteria not identified
Hydrolyses indospicine to
2-aminopimelamic acid and
2-aminopimelic acid followed by further






modified with dehalogenase gene
from Moraxella sp. strain B
Degrade toxic fluoroacetate into non-toxic
fluoride and acetate [68–73]
Pyrrolizidine alkaloids
Peptostreptococcus heliotrinreducens;
L4M2 mixed rumen bacterial culture







and heliotric acid [74–77]
Ingenol and ingenol esters Bacteria not identified Degradation pathway and metabolitesnot identified [78,79]
Microcystins and nodularin Bacteria not identified
Toxin degradation observed but
degradation pathway was
not identified [80]
Nivalenol and deoxynivalenol Eubacterium strain BBSH 797
Nivalenol and deoxynivalenol degraded
into their less-toxic de-epoxide
metabolites [81–85]
T-2 toxin and scirpentriol Eubacterium strain BBSH 797




Streptococcus sp. and Lactobacillus sp.
which may be present in the rumen
Degradation of aflatoxin B1 into less toxic
aflatoxicol, less toxic aflatoxin B2a and
non-toxic aflatoxin D1 [87]
Ochratoxin A Rumen protozoa; Bacillus lichenformis;Lactobacillus vitulinus
Hydrolysis of ochratoxin A into
non-toxic ochratoxin α
and phenylalanine [48,88–92]
Fumonisins Bacteria not identified Degradation pathway and metabolitesnot identified [93,94]
2. Rumen Microbial Detoxification of Plant Toxins
2.1. Non-Protein Amino Acids
Non-protein amino acids are plant secondary metabolites produced as a means to protect plants
from environmental stresses, including herbivory [95]. Non-protein amino acids are structurally
similar to proteinogenic amino acids which suggests both types of amino acids share similar synthetic
metabolic pathways [96]. This would mean both types of amino acids compete for the same enzyme
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co-factors and transporters which can disrupt biochemical pathways [97]. Non-protein amino acids
can be incorporated into protein chains leading to the formation of non-functional products that cannot
be metabolised [98]. The presence of non-protein amino acids in fodder poses risks to livestock due to
their potential toxicity and anti-nutritional properties [25,64,99]. There are ca.1000 known non-protein
amino acids [98] but this review will focus on the small number of toxic amino acids currently known
to be detoxified by rumen microorganisms.
2.1.1. Mimosine
A well-recognised example of the development of a protective microbial consortium for
detoxification of a plant toxin is the detoxification of the amino acid mimosine present in the
leucaena plant (Leucaena leucocephala). Leucaena is a high-protein leguminous shrub, originating from
the midlands of southern Mexico, Guatemala, El Salvador and Honduras [100], with use as a forage
feed in tropical and subtropical agricultural systems starting in the 1950s in Australia [101] and
Hawaii [102]. Feeding leucaena to cattle can result in leucaena toxicity with animals displaying
symptoms including hair loss, goitre, inappetence and poor cattle live-weight gain [14]. Mimosine was
reported to be degraded to 3,4-dihydroxypyridine (3,4-DHP) and 2,3-dihydroxypyridine (2,3-DHP) in
the rumen [103], with these degradation products shown to be toxic [104].
A study reported that goats and cattle from Hawaii maintained appetite and exhibited no clinical
signs of poisoning when fed leucaena exclusively [105]. By comparison, Australian ruminants exhibited
marked hypothyroidism within four weeks [15]. An in vitro experiment, incubating leucaena in fresh
rumen fluid showed Australian goat rumen fluid was able to rapidly convert mimosine to DHP but
no further, whilst the Hawaiian goat rumen fluid showed a marked decrease in both mimosine and
DHP levels [15]. A mixed bacterial culture, enriched from rumen fluid obtained from a Hawaiian
goat, was then used to inoculate a steer in Australia which was fed leucaena for over 12 months
without leucaena toxicity occurring and in vitro studies confirmed the presence of DHP-degrading
bacteria [61]. Subsequently a novel anaerobic rumen bacterium, Synergistes jonesii was isolated with
the ability to degrade 3,4-DHP to 2,3-DHP and 2,3-DHP to non-toxic products [62]. The development
and production of a mixed anaerobic bacterial inoculum containing S. jonesii, produced in an in vitro
fermenter, has enabled the adoption of leucaena as a fodder tree for cattle by Australian producers [63].
However, inoculation of buffalo rumen fluid containing S. jonesii into ruminants in eastern
Indonesia did not fully confer mimosine resistance as there was no significant decrease in 2,3-DHP
levels in the urine [106]. Halliday et al. [106] argued the possibility that the inoculum did not increase
the presence of ‘functional’ S. jonesii in the rumen and was ineffective in conferring complete resistance
to DHP toxicity. In China, four rumen-derived bacteria (two Lactobacillus spp., Streptococcus bovis and
Clostridium sporogenes) were isolated and identified with the ability to substantially degrade mimosine,
3,4-DHP and 2,3-DHP under in vitro conditions [107]. A rumen bacterium that was able to degrade
mimosine and DHP was isolated in Germany and identified to be an aero-tolerant gram-negative
coccobacillus belonging to the genus Klebsiella [108].
Mimosine degradation (Figure 1) to 3,4-DHP involves the de-alkylation of the amine group,
followed by isomerisation of 3,4-DHP to 2,3-DHP. Mimosine conversion to 3,4-DHP occurs via
enzymatic reaction by endogenous rumen bacteria [103] and endogenous plant enzymes within
leucaena leaves [104]. Isomerisation of 3,4-DHP to 2,3-DHP was suggested to be induced by an
isomerase in S. jonesii whilst a dehydrogenase produced by S. jonesii was predicted to be responsible
for the further degradation of 2,3-DHP [109]. Based on early studies, it was thought that mimosine
detoxification would require synergism between a variety of rumen microorganisms, with Jones
and Megarrity [15] demonstrating that there were a range of bacteria in the rumen able to degrade
mimosine to 3,4-DHP. A number of bacteria have been isolated including Streptococcus lutetiensis,
Clostridium butyricum, Lactobacillus vitulinus and Butyrivibrio fibrisolvens that are able to degrade
mimosine to DHP [99]. Additional bacteria such as S. jonesii are required for the further breakdown
of 3,4-DHP to 2,3-DHP which S. jonesii can further convert to unidentified non-toxic metabolites.
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Other rumen microorganisms may be also involved in the detoxification process in one way or another
with roles ranging from stabilisation of the ruminal ecosystem to providing nutrients or co-factors
required by the detoxifying bacteria [110].
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2.1.2. 4-N-Acetyl-2,4-diaminobuytric Acid (A-DABA)
Acacia angustissima is a tropical legume tree originating from Central America and has potential
as a fodder tree for ruminants because of its high levels of protein. A. angustissima toxicity was first
reported in sheep with poisoning symptoms including head pressing, grinding of teeth, foaming at the
mouth and jerking of the body [16], although the toxin was not then identified.
Several secondary metabolites of A. angustissima were proposed to be toxic including
condensed tannins, saponins and non-protein amino acids but their toxicity was not determined.
Extracted condensed tannins of A. angustissima when fed to rats showed tannins contributed
to the anti-nutritional effect but suggested the tannins were not the responsible toxins [112].
Non-protein amino acids such as 4-N-acetyl-2,4-diaminobutyric acid (A-DABA), diaminobutyric acid
(DABA) and 2,3-diaminopropionic acid (DAPA) are commonly present in A. angustissima [113].
A feeding trial with naïve sheep showed adaptation when A. angustissima was introduced
gradually, with increasing amounts fed over time resulting in no damage observed to their
internal organs [16]. The study did not report on the presence of metabolites in the rumen nor
isolate any toxin-degrading bacteria. Cross-inoculation of rumen contents from adapted sheep to
non-adapted sheep conferred detoxification ability to the acceptor sheep even when fed high amounts
of A. angustissima [16]. This result supported the hypothesis that rumen microorganisms play an
important role in detoxification of toxins present in A. angustissima and these microorganisms can be
transferred to non-adapted animals. A further study showed that DABA was the non-protein amino
acid responsible for the toxicity in A. angustissima, as poisoning symptoms were observed to be similar
to those caused by DABA in Lathyrus sylvestris (flatpea) [114].
A further in vitro study using enriched cultures obtained from rumen contents of sheep adapted to
A. angustissima demonstrated degradation of A-DABA, DABA and DAPA [64]. A-DABA was observed
to be hydrolysed to DABA (Figure 2i), as an intermediate, when incubated with the enriched culture
in a medium without carbohydrates but no intermediate was observed in A-DABA incubated in
media containing carbohydrates [64]. This suggests that the production of DABA as an intermediate of
A-DABA degradation could be due to bacteria utilising A-DABA as a nutrient source in the absence
of freely available carbohydrates. However, isolation of bacteria capable of degrading A-DABA and
DABA was unsuccessful [64]. The presence of DABA aminotransferase and decarboxylase previously
identified in several proteobacteria suggest the possibility that DABA is converted into diaminopropane
in the rumen [64]. On the other hand, two rumen bacterial strains able to metabolise DAPA were
successfully isolated and identified to belong to the Firmicutes phylum (strain LPLR3) and Klebsiella
genus (strain LPSR1) respectively based on 16S rRNA gene analysis [64]. Strain LPSR1 showed
degradation of DAPA in media containing carbohydrates while strain LPLR3 can grow and degrade
DAPA in media containing DAPA as the main carbon source [64]. The authors hypothesised that DAPA
degradation by strain LPLR3 was the result of its deamination to glutamate, as the molar amount of
ammonia produced was equal to the amount of DAPA degraded (Figure 2ii) [64].
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2.1.3. β-N-Oxalyl-l-α,β-diaminopropionic Acid (β-ODAP)
Lathyrus sativus (grass pea) is widely cultivated in western Asia, North Africa and the Indian
subcontinent as a forage crop with high dietary protein content [115]. The use of L. sativus however
is limited due to the presence of β-N-oxalyl-l-α,β-diaminopropionic acid (β-ODAP) (Figure 3),
a non-protein amino acid present in the seeds of L. sativus. Prolonged consumption of L. sativus seeds in
humans is often associated with the development of lathyrism which is a neurodegenerative syndrome
resulting in the paralysis of the lower limbs with β-ODAP identified as the toxin responsible [17].
Multiple studies were performed to elucidate the β-ODAP mode of action for inducing lathyrism but
were unsuccessful [18]. β-ODAP was also proposed to induce oxidative stress and excitotoxicity which
results in motor neuron degeneration [18,116]. Intraperitoneal administration of isolated β-ODAP to
chicks at the level of 20 mg/chick resulted in the development of neurological symptoms and persisted
up to 12 h while a higher administered dose of 30–60 mg/chick led to the symptoms persisting for up
to 24 h and even resulted in death [17]. Pathological studies on the effects of β-ODAP in sheep showed
nerve cell necrosis and degeneration in the cerebral cortex [117,118]. There are reported attempts to
detoxify β-ODAP in L. sativus either in-field or post-harvest to achieve safe utilisation of L. sativus
as food and fodder. L. sativus lines with low β-ODAP toxin levels were developed using traditional
breeding methods but lines free of β-ODAP have not yet been successfully produced [119]. There are
also efforts to genetically transform microorganisms with genes of enzymes capable of the hydrolysis
of β-ODAP [120].Toxins 2020, 12, x FOR PEER REVIEW 8 of 37 
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Efforts to isolate rumen microorganisms capable of degrading β-ODAP were reported.
Enrichment and isolation of rumen bacteria able to degrade β-ODAP was carried out using rumen fluid
of sheep (not previously exposed to L. sativus) incubated with culture medium containing concentrated
β-ODAP extract as the sole source of carbon and nitrogen [65]. Three isolates were identified as able to
degrade up to 46% β-ODAP in 24 h incubations [65]. The isolates were described morphologically to
be cocci and to be different from each other but they were not identified [65]. Enrichment and isolation
from cattle rumen contents incubated in medium containing β-ODAP as sole carbon source led to the
isolation of six isolates capable of degrading β-ODAP, where five isolates were Gram-negative and one
was Gram-positive [66]. 16S rRNA gene sequence analysis identified the isolates to be Megasphaera
elsdenii with five different genotypes and Clostridium bifermentans. The isolates were also reported to
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degrade 96% of β-ODAP within six days of incubation [66], however the degradation product(s) was
not reported.
2.1.4. Indospicine
Indigofera spp. are leguminous herbs and shrubs with more than 700 species found mostly
in subtropical and tropical regions [121]. These plants are of agronomical importance and widely
used as grazing forages and feed supplements as they are rich in protein and palatable to livestock.
However, the presence of indospicine in some Indigofera spp. has limited their agronomic potential.
Indospicine (2(S)-2,7-diamino-7-iminoheptanoic acid) is a non-protein amino acid analogue of arginine
which is present as the free amino acid in Indigofera plants [122]. Ingestion of indospicine was
shown to cause severe liver damage to monogastric animals such as dogs, mice and rabbits [123–125].
Dogs are highly susceptible to indospicine hepatotoxicity with reported cases of secondary poisoning
in dogs consuming indospicine-contaminated meat from horses and camels [126]. Indospicine could
not be degraded in mammalian tissue due to the presence of the unusual amidino group as no known
mammalian enzymes have the capacity to degrade this functional group [127].
Indospicine toxicity was observed in livestock consuming Indigofera plants with this amino acid
confirmed to be the responsible toxin through in vivo rodent toxicity studies [124]. Further studies
on indospicine described its toxicological effects in animals upon consumption. Since indospicine
shares similar chemical structure to arginine, indospicine was hypothesised to be able to disrupt
hepatic arginine-related protein synthesis leading to chronic liver damage. Indospicine was found
to be a competitive inhibitor to rat hepatic arginase with arginase having similar affinity towards
indospicine as to arginine, which negatively impacted aminoacylation of arginine causing urea cycle
disruption [128]. Indospicine was also shown to interfere with hepatic protein metabolism resulting in
fat accumulation and cytological changes in mice liver [124]. Indospicine was found to accumulate
in animal tissues leading to secondary poisoning as indospicine can remain in tissues over a long
period of time [123,129,130]. Indospicine has been shown to accumulate in cattle fed I. spicata with
slow depletion rates (t1/2 more than 30 days in muscle) [122]. Indospicine is found to be a competitive
inhibitor of arginyl-tRNA synthetase which prevents incorporation of arginine into tRNA affecting
ribosomal polypeptide synthesis [128]. Purified indospicine was found to cause cleft palate in mice
foetuses and had a high embryo-lethality [131].
Various studies reported ruminants grazing indospicine containing Indigofera plants, with
different observations depending on the feeding dose and animal species. Cattle suffering from
indospicine toxicity showed liver lesions, teratogenic and embryo-lethal effects [19]. There are reports
of cattle able to tolerate indospicine under normal grazing circumstances in Australia, Hawaii and
Kenya [132–134]. On the other hand, there are also studies which reported that cattle in Hawaii and Sri
Lanka that were fed fresh Indigofera plants over a period of weeks showed clinical signs of poisoning
with symptoms such as loss in body weight and liver lesions [21,134]. Cattle feeding on Indigofera
plants were also reported to suffer from reproductive losses. Studies in Africa, Hawaii and Fiji showed
that cattle that were fed with 16% to 100% Indigofera plants for their diet for over a month suffered
abortions and stillbirths in pregnant cows and heifers [20,23,24]. These studies suggest that indospicine
poisoning can be induced in cattle if they ingest large amount of Indigofera plants, with high intake of
indospicine, over an extended period of time. In extensive pastures of northern Australia where cattle
are not closely monitored, it is possible that similar instances of reproductive loss occur but are not
readily attributed to protracted Indigofera consumption [19].
Sheep grazing Indigofera plants experienced both hepatotoxic effects and embryo-lethality [19].
Feeding trials in Hawaii showed that sheep on Indigofera diet displayed more clinical signs of poisoning
compared to cattle, with sheep deaths occurring after 28 days. Post-mortem examination revealed
fatty degeneration of the liver [134]. Sheep fed I. spicata in Australia developed signs of poisoning
showing inappetence and weight loss with liver lesions [22]. Sheep are found to be able to tolerate
small amounts of Indigofera without signs of poisoning, as also seen in cattle. Feeding trials with
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sheep consuming small amounts of Indigofera in Australia, India and Kenya reported no apparent
signs of toxicity and Indigofera was highly palatable to sheep [132,133,135].
Indospicine which is an amidine was observed to be hydrolysed to the amide first, which is then
further hydrolysed to the corresponding acid [67]. Amidine hydrolysis to amide is known to occur
more rapidly under mild alkaline rather than acidic conditions [136]. Studies with pure indospicine
in dilute aqueous sodium carbonate resulted in the hydrolysis of indospicine to 2-aminopimelamic
acid, with further hydrolysis to 2-aminopimelic acid under dilute acidic conditions (1 N HCl, 120 ◦C,
2 h) [124]. Indospicine hydrolysis directly to 2-aminopimelic acid was also reported with concentrated
hydrochloric acid (6 N HCl, 120 ◦C, 20 h) [124]. Indospicine was also found to be stable under mild
acidic aqueous conditions in vitro and it was hypothesised that the mild acidic conditions in the
stomach would not be able to hydrolyse indospicine [137].
Free amino acids are known to be taken up by rumen microbes in either native or deaminated
form to produce ammonia as a nitrogen source for cellulolytic bacteria which means that indospicine
could be metabolised via deamination pathways in the rumen [67]. Therefore, there is potential for
rumen microorganisms to detoxify indospicine. Camel foregut fluid showed indospicine degradation
of 99% in 48 h in an in vitro incubation study [67]. In a similar study, degradation of indospicine by
cattle rumen fluid showed degradation levels of 97% after 48 h incubation [67]. However, the efficiency
of indospicine degradation in vitro could not be translated to produce similar efficiency in vivo, as the
solubility of indospicine allows the toxin to have a short ruminal retention time before moving into
the intestine and being rapidly absorbed into blood plasma and tissues of animals. Cattle rumen
metabolism of indospicine was hypothesised to be similar to that in camel foregut fluid. The camel
is a unique non-ruminant herbivore that possesses a compartmental stomach and extensive foregut
fermentation processes, such that researchers sometimes refer to camels as “pseudoruminants” [138].
The study also reported indospicine to be hydrolysed into 2-aminopimelamic acid and 2-aminopimelic
acid (Figure 4) followed by further metabolism [67]. Although indospicine is an analogue of arginine,
it does not follow a similar metabolic pathway to arginine when metabolised by rumen microbes.
Instead, formation of 2-aminopimelamic acid was found to follow a similar pathway to the formation
of citrulline from arginine, but the absence of nitrogen adjacent to the amide prevented ornithine
equivalent metabolite formation [67]. There is no reported knowledge on the toxicity of both indospicine
metabolites. The reported in vitro indospicine degradation by camel gut fluid and cattle rumen fluid
suggested the potential of rumen microorganisms to be used as probiotics against the toxin. However,
such ambition is perhaps compromised by the solubility of indospicine and the lack of binding of
indospicine in tissues [123].
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2.2. Fluoroacetate
Fluoroacetate (FCH2COO−) is a highly toxic compound, found in over 40 plant species [139],
which is responsible for fatal poisonings of ruminants [25,26], and also used as a potent pesticide
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to control mammalian pest species [140]. The mechanism of fluoroacetate toxicity is well known,
fluoroacetate is absorbed through the gut and converted to fluorocitrate, which binds strongly to the
aconitase enzyme in the tricarboxylic acid (TCA) cycle thus terminating cellular respiration due to
aconitase shortage [140,141]. Citrate builds up in tissues and blood, causing symptoms of toxicity
including acidosis, hypocalcaemia and heart failure [27]. Fluoroacetate can be usually found in tropical
and subtropical plants from the southern continents of Australia, South America and Africa belonging
to the plant families of Fabaceae, Rubiaceae and Malpighiaceae [142], with such plants posing a
significant risk to grazing livestock [19,78].
Despite studies reporting on fluoroacetate poisoning across many animals [143–145], some wildlife
species are found to possess an innate tolerance to fluoroacetate compared to other animals. Animals in
Australia such as Tiliqua rugosa (skink) were reported to have 100-fold tolerance to fluoroacetate [146]
while Dromaius novaehollandiae (emu) that foraged in areas with fluoroacetate-accumulating plants were
found to be 150 times more tolerant to fluoroacetate compared to emus foraging outside these areas [147].
Intraperitoneal administration of sodium fluoroacetate to tammar wallaby (Macropus eugenii) from
Western Australia that was not exposed to any fluoroacetate-containing plants prior to the study showed
tolerance against fluoroacetate poisoning [148]. These observations led to the proposed hypothesis
that fluoroacetate tolerance is due to the lower metabolic rate in these animals which slowed the
rate of fluoroacetate absorption and metabolism thus allowing these animals to excrete or detoxify
fluoroacetate [149].
It was reported that feeding repeated low non-toxic doses of fluoroacetate containing plants to
ruminants will confer resistance against fluoroacetate poisoning [150]. Furthermore, the resistance can
be transferred to naïve animals through ruminal fluid transfer from experienced animals. Goats that
were fed with increasing doses of fluoroacetate containing Amorimia septentrionalis in alternating periods,
showed that the adapted goats possessed resistance against fluoroacetate poisoning while transfaunated
goats, with adapted rumen fluid, showed clinical signs of poisoning much later compared to control
goats [151]. Resistance against fluoroacetate poisoning was also observed in sheep fed with non-toxic
doses of Amorimia pubiflora while transfaunated sheep, with adapted rumen fluid, showed initial clinical
poisoning symptoms significantly later than the control group [150]. Although the above-mentioned
studies did not report on any rumen bacteria isolations responsible for fluoroacetate degradation,
it is predicted that these rumen bacteria would possess fluoroacetate dehalogenase activity capable
of reductively breaking the carbon-fluorine bond in fluoroacetate [152]. Rumen microorganisms
from un-adapted cattle rumen fluid that were enriched in the presence of fluoroacetate as carbon
source resulted in the selection and isolation of a novel rumen bacterium capable of degrading
fluoroacetate [68]. This bacterial strain was identified to be a Synergistes sp. and was able to degrade
fluoroacetate (FCH2COO−) producing fluoride (F−) and acetate (CH3COO−) [68,69]. A recent study
reported the isolation of rumen bacteria from the genera Enterococcus and Bacillus in media containing
sodium fluoroacetate as the sole carbon source [153]. However, a study administering increasing
subclinical doses of pure sodium fluoroacetate directly into a goat’s rumen did not result in the animal
developing resistance against fluoroacetate [154].
An in vitro study using ovine rumen fluid, from an animal that did not previously graze
fluoroacetate-containing plants, incubated in growth media with sodium fluoroacetate as the sole
carbon source resulted in the isolation of two isolates capable of fluoroacetate degradation. 16S rRNA
gene sequencing of both isolates identified as being Pigmentiphaga and Ancylobacter species [70].
Incubation of both isolates in media culture containing 20 mmol/L of sodium fluoroacetate resulted in
the complete release of fluoride ions after 32 h of incubation [70]. A recent in vitro inoculation study
using Australian cattle rumen fluid in culture medium containing fluoroacetate resulted in the isolation
of a rumen bacterium which was identified as belonging to the Synergistetes phylum and in the genus
Pyramidobacter [71]. The isolated Pyramidobacter strain was suggested to have similar fluoroacetate
detoxifying functions to the previously reported bacterium from Davis et al. [68] and was found to
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be present in higher numbers, based on quantitative PCR analysis of collected rumen fluid, in cattle
across northern Australia [71].
Experimental inoculation of ruminants with Butyrivibrio fibrisolvens bacteria genetically modified
with a dehalogenase gene from the soil bacterium Moraxella sp. strain B showed success in preventing
fluoroacetate poisoning in ruminants [72]. A further study involving genetically modified B. fibriosolvens
strains transformed with dehalogenase genes inoculated into sheep showed the inoculated sheep to be
resistant against fluoroacetate poisoning [73]. However, concerns over transgenic bacteria prevented
the commercial use of such an approach to mitigate fluoroacetate poisoning in ruminants.
2.3. Pyrrolizidine Alkaloids
Alkaloids are a diverse group of amino acid-derived and nitrogen-bearing molecules present
in plants. They are low molecular weight structures which make up 20% of plant based secondary
metabolites. Alkaloids are known for their diverse bioactive properties ranging from toxicity to
pharmacological properties [155,156]. Pyrrolizidine alkaloids (PA) are secondary metabolites produced
by about 3% of all flowering plant species as protection against herbivory [157]. There are more
than 660 PAs and N-oxide derivatives identified in over 6000 plants of four families, Apocynaceae,
Asteraceae (Compositae), Boraginaceae and Fabaceae (Leguminosae) with half of these PAs reported
to have toxic activities [158]. PAs are heterocyclic compounds consisting a necine base esterified with
one or more necic acids. Generally, naturally occurring PAs present in plants are esterified necines and
frequently occur as the N-oxide (PANO) [159]. PAs can be classified into four groups based on the
structure of the necine base which are retronecine, heliotridine, otonecine and platynecine. Necic acids
are aliphatic carboxylic acids derived from amino acids, ranging from simple acids to more complex di-
and mono-carboxylic acids containing 7, 8 or 10 carbons, and are joined to the necine bases at either
the 7-OH or 9-OH positions [159].
The toxicity of PAs is well documented. PA intoxication can cause acute, sub-acute or chronic
toxicity where acute intoxication manifests as haemorrhagic necrosis, sub-acute toxicity causes blockage
of hepatic veins, and chronic toxicity can lead to liver failure and death [159–161]. PAs of heliotridine-,
retronecine- and otonecine-types are known to cause genotoxicity and tumorigenicity through
formation of DNA adducts with dehydropyrrolizidine alkaloids (DHPA) [159]. PAs also undergo
photosensitization causing oxidative stress and lipid peroxidation leading to tumour formation [162].
PAs are also reported to cause lung damage when DHPA travels into the pulmonary arterioles
causing thrombi in vessels and thickening in lung walls leading to occlusion and inflammation [163].
Neurotoxicity by PAs is seen in necrotic lesions in the central nervous system [164].
Metabolism of PAs is required for toxicity bioactivation. PAs are usually orally ingested and
absorbed into the body from the gastrointestinal tract [159]. Bioactivation of PA mostly occurs in the
liver thus making this organ the most affected by PA toxicity. In general, there are three principal PA
metabolic pathways. The first metabolic pathway involves hydrolysis of the ester groups linked to the
C7 and C9 positions to produce necines and necic acids by liver microsomal carboxylesterases [160].
The second metabolic pathway is the N-oxidation of the necine base of PAs forming pyrrolizidine
alkaloid N-oxides which can be conjugated allowing for excretion [160]. The third metabolic pathway
is the oxidation of PA to form pyrrolic esters or DHPA [160]. Hydrolysis and N-oxidation of PA
are considered to be the main detoxification route for PA removal from the body [165]. However,
PA N-oxides can be converted back into PAs and be oxidised into DHPA by CYP450 monooxygenases,
notably CYP3A and CYP3B [163]. Not all PA types can be metabolised by all three pathways.
Retronecine- and heliotridine-type PAs can be metabolised by all three principal metabolic pathways
(Figure 5) [159]. On the other hand, otonecine-type PAs have necine bases which are structurally
different than retronecine- and heliotridine-type PAs and oxidative N-demethylation of the necine base
precedes further metabolism [159].
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PAs are highly toxic to both monogastric a r i a t er i ores and present a constant issue
for livestock industries [16 ]. Further ore, t ilit f t e transfe red and contaminate food
products uch as honey, milk and dairy pro considered as a severe health risk [166].
Ruminants are resistant and are seldom reported to show acute poisoning but xp rience
sub-acu e to chronic toxicity [32]. Clinical symptoms of ruminant PA ntoxication include loss of
appetite, diarrhoea and depression [28]. Livestock losses w re reported in the United States due to
livestock grazing PA contai ing pla ts f Senecio jacobaea (tansy ragwort) [29] while PA i t xication of
poultry, cattle, horses and pigs in Australia has identified PA containing plants Heliotropium europaeum
(European heliotrope) and Echium plantagineum (Paterson’s curse) to be responsible [167–171]. Calves fed
with S. jacobaea in doses of 1.3 kg/day (3 mg/kg bodyweight (bw) PA) resulted in megalocytosis after
182 days [32]. Calves fed with a single dose of 60 mg/kg bw PAs from Cynoglossum officinale (hound’s
tongue) resulted in animal deaths within 48 h, whilst daily cattle feeding PAs with a dose of 15 mg/kg
bw for 21 days showed hepatocellular necrosis by day 35 [30]. Goat kids and lactating dairy goats fed
dried S. jacobea as 25% of a complete diet reported chronic clinical symptoms while cattle and horses
with intakes of 0.05 and 0.20 kg/kg bw of S. jacobea respectively were lethal [31]. The study suggested
that goats are more resistant to PAs compared to cattle and horses [31].
Resistance to PA poisoning was previously reported in sheep where the detoxification was
hypothesised to occur in the rumen, suggesting that sheep rumen microorganisms have the ability to
metabolise PAs and render them non-toxic [74,172]. Resistance against PA poisoning was reported to
only occur in animals that were previously exposed to the toxin allowing rumen microbes to adapt
to metabolise PAs. In confirmation, in vitro incubation of PAs that were commercially purchased or
isolated from PA-containing seeds using ruminal contents from naïve sheep and cattle resulted in no PA
degradation and the PAs remained stable in the incubation [173]. In contrast, sheep fed daily with 10 g/kg
bw of dried Heliotropium ovalifolium (grey leaf heliotrope) did not show any poisoning symptoms [174]
and o poisoning was reported in sheep f d daily with 105 mg/kg bw of E. plant gi eum [175].
In vitro incubation of the PA heliotr ne in rumen fluid from Australian Merin wethers, f d on green
ryegrass-white clov r diet, showed heliotrine degradation by a bacte ium that was described to be
Gram-negative, micrococcus, growing in pairs, short chains and clumps [75]. The bacterium was
obse ved to reduce trine (Figure 6) into 7α-hydroxy-1-methylene-8α-pyrrolizidine and heliot ic
acid in the prese ce of format or mol cular hydroge as hydrogen donor [75]. Incubation of heliotrine
in rumen fluid of Merino × Border Leicester ewes and wethers fed with dried H. europaeum resulted in
the isolation of a bioactive strain which was named Peptostreptococcus heliotrinreducens [74]. This study
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was in agreement with Russell and Smith [75] and showed that formate and hydrogen were required
for P. heliotrinreducens growth. P. heliotrinreducens was able to degrade other PAs including europine,
lasiocarpine, supinine and heleurine to form 1-methylene derivatives similar to the metabolites
observed by Russell and Smith [75] in modified media [74]. Both studies did not report any toxicity of
the 1-methylene derivatives of PAs which suggest the possibility of successful PA detoxification by
ovine rumen bacteria. This shows that PAs can be detoxified by reducing the 1,2 double-bond of the
necine moiety. The presence of rumen bacteria in sheep that are able to detoxify PAs may be utilised for
cross-inoculation to other ruminants thus conferring immunity to other ruminants when ingesting PAs.
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showed potential to be used as a probiotic against plants containing PAs. Isolation work of the L4M2 
rumen microbial culture to identify rumen bacteria responsible for PA degradation resulted in the 
isolation of six bacterial isolates but these isolates were unable to degrade macrocyclic PAs and could 
not be identified using 16S rRNA gene sequencing [176]. Bacterial characterisation of enriched L4M2 
culture using denaturing gradient gel electrophoresis and PCR cloning in a later study resulted in the 
classification of several genera of bacteria based on 16S rRNA gene sequences including Anaerovibrio, 
Desulfovibrio, Megasphaera, Prevotella and Synergistes [77]. 
2.4. Diterpenoids of Leafy Spurge 
Euphorbia esula L. (leafy spurge) is a deep-rooted perennial, noxious weed growing in the 
rangelands and pastures in many areas of the northern Great Plains of North America and southern 
Canada since the early 1900s [177]. Leafy spurge has high nutritive value based on crude protein 
content with comparable values to other grazed pasture species such as alfalfa [178]. However, 
domesticated livestock, especially cattle, and wildlife tend to avoid grazing leafy spurge [33]. Since 
cattle are the predominant grazing livestock in North America, their aversion to leafy spurge is 
deemed to be one of the main reasons for the infestation of this introduced plant across two million 
acres of range and pasture lands in the United States alone [179]. Management strategies such as 
i r . r s t lic t f li tri r ti ( t fr [ ]).
A later study showed the synergistic relationship of ruminal microorganisms in metabolising
S. jacobaea PAs. It was reported that a group of unidentified ruminal bacteria were responsible for PA
metabolism while ruminal protozoa may have been involved in increasing the rate of degradation [172].
This could be due to the presence of protozoa and certain bacteria that could be responsible for the
adsorption or adherence of PA-degrading bacteria to plant particles thus allowing the metabolising
bacteria to utilise PAs [172].
Another in vitro incubation study compared the metabolism of monoester PA, diester PA and
macrocyclic PA by either a mixed rumen bacteria culture (L4M2) obtained from rumen fluid of sheep
that was fed with S. jacobaea as their diet or a commercially purchased P. heliotrinreducens (ATCC
strain 29202) originally isolated from Australian sheep rumen fluid [76]. The study reported that
P. heliotrinreducens was able to completely metabolise heliotrine (monoester PA) and lasiocarpine
(diester PA) within 16 h of incubation but was unable to metabolise macrocyclic PAs throughout the
24 h incubation period [76]. The mixed L4M2 culture on the other hand was able to metabolise all
three types of PAs and in shorter incubation times compared to P. heliotrinreducens [76]. All PAs were
shown to be metabolised to their respective 1-methylene product and the L4M2 culture was found to
be possibly able to further metabolise the 1-methylene PAs further [76]. Therefore, the L4M2 culture
showed potential to be used as a probiotic against plants containing PAs. Isolation work of the L4M2
rumen microbial culture to identify rumen bacteria responsible for PA degradation resulted in the
isolation of six bacterial isolates but these isolates were unable to degrade macrocyclic PAs and could
not be identified using 16S rRNA gene sequencing [176]. Bacterial characterisation of enriched L4M2
culture using denaturing gradient gel electrophoresis and PCR cloning in a later study resulted in the
classification of several genera of bacteria based on 16S rRNA gene sequences including Anaerovibrio,
Desulfovibrio, Megasphaera, Prevotella and Synergistes [77].
2.4. Diterpenoids of Leafy Spurge
Euphorbia esula L. (leafy spurge) is a deep-rooted perennial, noxious weed growing in the rangelands
and pastures in many areas of the northern Great Plains of North America and southern Canada
since the early 1900s [177]. Leafy spurge has high nutritive value based on crude protein content with
comparable values to other grazed pasture species such as alfalfa [178]. However, domesticated livestock,
especially cattle, and wildlife tend to avoid grazing leafy spurge [33]. Since cattle are the predominant
grazing livestock in North America, their aversion to leafy spurge is deemed to be one of the main
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reasons for the infestation of this introduced plant across two million acres of range and pasture lands
in the United States alone [179]. Management strategies such as herbicides and intensive grazing
were applied as a means to control leafy spurge infested lands but complete eradication of leafy
spurge has been deemed to be economically unfeasible [180]. No poisoning of livestock from ingestion
of leafy spurge in pastures and rangelands has been reported and this could be due to ruminants
either avoiding grazing leafy spurge or having the ability to tolerate them. Not all grazing ruminants
however were reported to have aversion to leafy spurge. Native sheep and goats were found to graze
leafy spurge readily and domestic sheep were found to consume leafy spurge up to 50% of their
daily dry matter intake [181]. Goats were observed to graze leafy spurge more willingly compared to
sheep [182]. These observations suggest that goats and sheep may possess rumen microbial populations
that are capable of metabolising leafy spurge secondary metabolites whilst the cattle rumen do not.
The ability of sheep and goats to tolerate leafy spurge has been utilised as a biological control strategy
to control leafy spurge invasion in pastures as this strategy is considered to be cost-effective and easy
to implement compared to the use of herbicides [183].
Aversion to leafy spurge in cattle has been associated with condensed tannins and diterpenoids
present in leafy spurge with these secondary metabolites being correlated with digestive upset in
cattle when they ingest low doses of leafy spurge [184]. Ingenol (Figure 7i) and ingenol esters are
some of the diterpenoids identified from extracts of leafy spurge which are found to be an irritant
and a tumour promoter [34]. Both ingenol and its esters are suggested to induce toxicity due to their
structural similarity to diacylglycerol and so mimic diacylglycerol thus activating protein kinase C [185].
The irreversible activation of protein kinase C has been documented to cause metabolic disruption
leading to inflammatory response such as tissue damage, release of histamine causing irritation,
unregulated cell growth and differentiation which could cause tumour formation [186].
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ingenol-20-dodecanoate, 3-acetate (Figure 7ii) showed reduction of feed intake up to 89% on the 
second day [179]. Toxicity of isolated ingenol was found to be lower compared to its ester derivative 
of ingenol-20-dodecanoate, 3-acetate when tested on bovine lymphosarcoma cells [179]. The lower 
toxicity of ingenol compared to its ester also suggest that ingenol esters to elicit more aversion 
response than the parent ingenol. This could be due to ingenol esters being more lipophilic than 
ingenol thus they are more likely to be absorbed through the intestinal mucosa [188]. Leafy spurge 
extract incubated in pure cultures of common ruminal bacteria consisting of Butyrivibrio fibrisolvens, 
Fibrobacter succinogens, Lachnospira multipara, Prevotella ruminicola, Selenomonas ruminantium and 
Streptococcus bovis did not cause significant negative effect on their growth suggesting that the toxicity 
mechanism of leafy spurge extract did not involve the inhibition of feed digestion by rumen microbes 
[188]. 
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secondary metabolites. Sheep did not elicit aversion when fed with leafy spurge that was fermented 
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Ingenol and ingenol esters are also reported to be partly responsible for the aversion developed
in cattle to leafy spurge. Ingested ingenol was hypothesised to be absorbed into the blood from the
gastrointestinal tract which then travels to the area postrema in the medulla oblongata in the brain
leading to the development of conditioned aversion [187]. A feeding trial on cattle with feed treated
with ingenol resulted in decreased feed intake by 83% on the second day while feed treated with
ingenol-20-dodecanoate, 3-acetate (Figure 7ii) showed reduction of feed intake up to 89% on the
second day [179]. Toxicity of isolated ingenol was found to be lower compared to its ester derivative
of ingenol-20-dodecanoate, 3-acetate when tested on bovine lymphosarcoma cells [179]. The lower
toxicity of ingenol compared to its ester also suggest that ingenol esters to elicit more aversion response
than the parent ingenol. This could be due to ingenol esters being more lipophilic than ingenol thus they
are more likely to be absorbed through the intestinal mucosa [188]. Leafy spurge extract incubated in
pure cultures of common ruminal bacteria consisting of Butyrivibrio fibrisolvens, Fibrobacter succinogens,
Lachnospira multipara, Prevotella ruminicola, Selenomonas ruminantium and Streptococcus bovis did not
cause significant negative effect on their growth suggesting that the toxicity mechanism of leafy spurge
extract did not involve the inhibition of feed digestion by rumen microbes [188].
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Studies were done to determine the ability of rumen microorganisms to metabolise leafy spurge
secondary metabolites. Sheep did not elicit aversion when fed with leafy spurge that was fermented
in vitro in goat ruminal digesta but showed aversion to leafy spurge fermented in sheep ruminal
digesta [78]. The study suggested that the aversive compounds present in leafy spurge were detoxified
by rumen microorganism in goat rumen contents reflecting the difference in the ruminal microbiome
of goats and sheep [78]. The study also confirmed previous observations that goats were able to
graze leafy spurge more readily than sheep. Further studies to investigate the biotransformation of
leafy spurge by rumen microorganisms and the identification of rumen microbes responsible for the
degradation are required. In vitro digestibility of leafy spurge inoculated with rumen fluid of cattle
or sheep that were either previously exposed or naïve to leafy spurge showed that the in vitro dry
matter digestibility increased in rumen fluid previously exposed to leafy spurge while decrease in
in vitro dry matter digestibility in naïve rumen fluid [180]. Another in vitro incubation study using
rumen content of cattle and sheep fed with 2% dry matter/bw of leafy spurge reported improved
dry matter digestibility compared to when using rumen content that was not previously exposed to
leafy spurge [79]. The studies suggested that previous exposure to leafy spurge may alter the rumen
microbial population to adapt to leafy spurge metabolites. However, this does not mean the adapted
rumen digesta are able to detoxify toxic secondary metabolites of leafy spurge.
3. Rumen Microbial Detoxification of Cyanotoxins
Cyanobacteria (blue-green algae) can be commonly found in both fresh and sea waters. They play
a key role in the ecosystem and biodiversity as primary producers, oxygen producers and in nitrogen
fixation. Formation of algal blooms by cyanobacteria is caused by eutrophication which is an
increasing environmental occurrence in the world. These blooms are considered to be potential
health hazards as some cyanobacteria are able to produce cyanotoxins which are released into the
water when the cells rupture or die. Every cyanobacteria species produces different cyanotoxins
that can be classified according to the organs affected by toxicity. Generally, cyanotoxins vary in
their toxicology. Chronic exposure of low doses of hepatotoxic cyanotoxins are associated with
tumour growth, hepatocyte degeneration with necrosis, progressive fibrosis and mononuclear
leukocyte infiltration [36,39]. Neurotoxic cyanotoxins are proposed to be a contributing factor for
neurodegenerative diseases [37]. Cyanotoxins are also found to be protein inhibitors, causing DNA
damage and genotoxicity and they induce oxidative stress [38,40,41]. Cyanotoxin exposure can occur
directly or indirectly. Direct exposure of cyanotoxins mainly involves ingestion of contaminated
water while indirect exposure includes consumption of animal or plant products contaminated
with cyanotoxins. Cyanotoxins are reported to be able to bio-accumulate, causing their toxic effect
to be magnified in food chains [189]. Reports of animal poisoning caused by cyanotoxins are well
documented worldwide ranging from fish, domestic animals and livestock which include ruminants [35].
Livestock poisoning associated with cyanotoxins is a major concern as it causes economic losses and
reduced animal performance. Sudden livestock death associated with cyanotoxin poisoning has been
reported in Australia, United States and Canada [35].
Microcystins are cyclic heptapeptides produced by cyanobacteria species of Microcystis, Oscillatoria,
Anabaena and Nostoc and are known to be potent hepatotoxins [190] and tumour promoters [191].
Microcystin-LR (Figure 8) administered through intraperitoneal injection and oral administration to
rats showed that rats given microcystin orally were less susceptible to the toxic effects compared to
peritoneal administration, suggesting the role of detoxification by gut microorganisms or mechanisms
that inhibited cyanotoxin absorption in the gastrointestinal tract [192]. Manubolu et al. [80] hypothesised
that rumen microorganisms may have the ability to detoxify cyanotoxins and an in vitro incubation
study was done using whole rumen contents from cattle that were not previously exposed to
cyanotoxins. The rumen contents were incubated with cyanotoxins of microcystins (microcystin-LR,
microcystin-RR and microcystin-YR) and nodularin for three hours and the degradation of the
cyanotoxins were determined. Degradation of these cyanotoxins was observed with the degree of
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degradation determined to be dose and time dependent. Microcystins and nodularin showed higher
rates of degradation of up to 36% by rumen fluid at low dose concentrations of 0.05 µg/mL while higher
doses of cyanotoxins at 0.5 µg/mL and 5 µg/mL showed lower degradation rates and no degradation
rate respectively [80]. Highest degradation rate was also observed in microcystin-YR at the first hour
and rapidly decreased at the third hour [80]. The study showed the potential of rumen microbial
flora to degrade cyanotoxins. However, no rumen microorganisms were isolated or identified and no
metabolic pathway was determined from the incubation study.
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with causing reproductive disorders in farm animals were found to form metabolites that are more 
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such as neosolaniol which possess a hydroxyl group at C8 on its structure, T-2 toxin which has an 
ester function at C8 and diacetoxyscirpenol that has no oxygen substitution at C8 [201]. Nivalenol 
(NIV), deoxynivalenol (DON) and trichothecin are type B trichothecenes possessing a carbonyl group 
at C8 of their structure. Type C trichothecenes have a C7/C8 epoxide while type D trichothecenes have 
an additional ring that is linked via esters at the C4 and C15 hydroxyls [201]. This classification is 
commonly used to distinguish between trichothecenes but there are other structural features that are 
not accounted for in the system.  
4. Rumen Microbial Detoxification of Mycotoxins
Mycotoxins are secondary metabolites produced by fungi that can be toxic to both animals and
humans [193]. Food and animal feed are highly susceptible to fungal growth and contamination in the
field or during storage and the fungal species responsible determines the different mycotoxins which can
be present. The Food and Agriculture Organisation (FAO) of the United Nations reported that 25% of the
world’s food production is contaminated by at least one mycotoxin [194]. Commonly found mycotoxins
include aflatoxin, fumonisins and trichothecenes which are large contributors to most agricultural
mycotoxin poisoning concerns [195]. Clinical toxicological studies of high mycotoxin consumption
showed various health issues ranging from acute mortality, slowed growth, gastrointestinal disorders,
altered nutritional efficiency and reduced reproductive efficiency [196]. Monogastric animals are more
susceptible to mycotoxins compared to ruminants as the rumen contains microorganisms which secrete
enzymes that are capable of degrading the mycotoxins to less toxic or non-toxic metabolites [196–198].
However, not all mycotoxins can be detoxified by rumen microorganisms. Zearalenone which is a
nonsteroidal estrogenic mycotoxin commonly associated with causing reproductive disorders in farm
animals were found to form metabolites that are more toxic than the parent toxin [199,200].
4.1. Trichothecenes
Trichothecenes are a class of mycotoxins, produced mostly by a number of fungal species namely
Fusarium, Trichoderma, Cephalosporium, Myrothecium, Spicellum, Stachybotrys and Trichothecium, which are
harmful to human and animals’ health causing a wide range of acute and chronic symptoms [201].
Trichothecenes share a common tricyclic 12,13-epoxytrichothec-9-ene core structure and are
divided into four groups (types A–D) (Figure 9) depending on their producer fungi and substitution
pattern on the core [201]. Both trichothecenes types A and B are chemically distinguished by the
presence of an oxygen or carbonyl functional group at C8 position respectively. Type A trichothecenes
such as neosolaniol which possess a hydroxyl group at C8 on its structure, T-2 toxin which has an ester
function at C8 and diacetoxyscirpenol that has no oxygen substitution at C8 [201]. Nivalenol (NIV),
deoxynivalenol (DON) and trichothecin are type B trichothecenes possessing a carbonyl group at
C8 of their structure. Type C trichothecenes have a C7/C8 epoxide while type D trichothecenes have
an additional ring that is linked via esters at the C4 and C15 hydroxyls [201]. This classification is
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commonly used to distinguish between trichothecenes but there are other structural features that are
not accounted for in the system.Toxins 2020, 12, x FOR PEER REVIEW 17 of 37 
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Trichothecenes enter the host body through ingestion and are absorbed via the intergumentary
and gastrointestinal systems as they can move passively across cell membranes. Trichothecenes are
stable at neutral and acidic pH conditions making them stable and not hydrolysed in the stomach
during digestion [201]. Toxicity of trichothecenes has been previously reviewed extensively [202,203].
Trichothecenes are toxic to all tested animal species but the sensitivity towards each trichothecene varies
between organisms. Trichothecenes elicit toxic effects on animals which include immunosuppression,
reduced growth rate, reproductive disorders, feed refusal and vomiting [42]. Early toxicity studies
reported that trichothecenes inhibited eukaryotic protein synthesis by preventing the formation
of peptide bond at the peptidyl transferase centre of the 60S ribosomal subunit affecting not
only polypeptide chain initiation or elongation but also causing inhibition of polypeptide chain
termination [43]. Trichothecenes are responsible for the inhibition of mitochondrial protein synthesis,
inhibition of sulfhydryl enzymes and generation of free radicals causing harmful levels of oxidative
stress [42,44]. Trichothecenes also inhibited cell growth and mitosis, with in vitro studies using both
human cell lines and plants showing growth inhibition in every phase of the growth cycle [204].
Only types A and B are commonly found in crops which are mainly produced by Fusarium.
NIV and DON (Figure 10) are type B trichothecenes which are commonly found in cereals grown in
temperate areas of America, Europe and Asia. The maximum allowable level of DON in food and feed
set by the European Commission regulation (EU) 1881/2006, amended by the European Commission
regulation (EU) 1126/2007 is 1250 µg/kg while the level of NIV was not set in the EU regulation [205].
NIV and DON are chemically stable due to their trichothecene skeleton and the epoxide ring is stable
against nucleophilic attack. The epoxide group of trichothecenes is generally considered to be essential
for its toxicity [206]. Detoxification of trichothecenes was previously observed when the oxygen in the
epoxide group was removed to give a carbon-carbon double bond, resulting in non-toxic de-epoxy
metabolites. De-epoxy T-2 toxin was observed to be 200 times less toxic than T-2 toxin in rat skin
irritation assay [207]. Furthermore, de-epoxy T-2 toxin metabolites were 50 times less toxic compared to
metabolites that had intact epoxides when tested in a brine shrimp LC50 test [208]. Cytotoxicity assays
using a BrdU bioassay showed that de-epoxy NIV and de-epoxy DON (DOM-1) had higher IC50 values
of 64.2 mM and 83 mM respectively, compared to NIV and DON, which had IC50 value of 1.19 mM
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and 1.5 mM respectively, suggesting the de-epoxides are less cytotoxic than their corresponding
trichothecenes [209]. These studies suggested that the detoxification is a single step reaction where the
epoxide is reduced thus reducing the toxicity effect of trichothecenes.
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The de-epoxide trichothecenes are suggested to be metabolites of intestinal or ruminal microbes 
as they were found in urine of rats and in urine and plasma of cattle [82,210,211]. Pig intestinal content 
and faeces microbes were found to transform trichothecenes to their respective de-epoxides [207,212,213]. 
The de-epoxidation step has been considered to occur in the intestines prior to absorption but the 
experimental evidence for this claim is weak as no de-epoxide metabolites were found in liver 
homogenates nor in in vitro incubation with pig intestinal content from duodenum or jejunum [212]. 
However, de-epoxide metabolites were found in in vitro incubations with intestinal content of pig 
caecum, rectum and colon [212].  
It was previously reported that rumen microorganisms were capable of degrading NIV and 
DON into their respective de-epoxide metabolites (Figure 10). In vitro rumen fermentation of DON 
at concentrations equivalent to 5 ppm and 10 ppm in feed, showed about 89% of DON was reduced 
within 48 h of incubation [81]. The study also reported that the amount of trichothecenes in the feed 
can affect the rate of transformation such that when DON was incubated at concentrations equivalent 
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microbes [81]. In vitro incubation of 2 ppm NIV and DON in rumen fluid collected from Swedish Red 
and White cows for 48 h resulted in 82% of NIV and DON converted into de-epoxy NIV and DOM-1 
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DON was found to be de-epoxidised after six hours of incubation [83]. An in vivo trial in which 
lactating Holstein cows were fed naturally DON-contaminated corn showed DON to be metabolised 
to DOM-1 and the metabolite was found to be excreted in urine, plasma and milk [82]. Other DON 
metabolites were also identified from studies involving orally administered DON into sheep where 
glucuronide conjugated DON, glucuronide conjugated DOM-1 and sulfate conjugated DON were 
detected in urine and bile [84]. Anaerobic in vitro incubation of 1000 ppm DON in rumen fluid 
collected from cannulated cattle showed 35% of DON was de-epoxidised after 96 h [85]. 
A study using in vitro incubation of 100 ppm DON in cattle rumen fluid showed 
biotransformation of DON into DOM-1 and resulted in the isolation of a bioactive microorganism, 
identified as an anaerobic Gram-positive bacterium [214]. Further study of the bacterium indicated a 
new species within the genus Eubacterium, designated Eubacterium strain BBSH 797 [215]. The isolated 
strain was further developed into a commercial product for trichothecene detoxification in animal 
feed designed for poultry and swine diets under the brand name Mycofix® . A modified in vitro test 
model with pig intestine inoculated with Eubacterium strain BBSH 797 and incubated with DON 
showed formation of DOM-1 [88]. Toxicity test showed that DOM-1 was 500 times less toxic than 
DON [88]. In vitro incubation of BBSH 797 with type A trichothecenes, T-2 toxin and scirpentriol 
i r . r s t li t s f (i) I (ii) r ti .
The de-epoxide trichothecenes are suggested to be metabolites of intestinal or ruminal microbes as
they were found in urine of rats and in urine and plasma of cattle [82,210,211]. Pig intestinal content and
faeces microbes were found to transform trichothecenes to their respective de-epoxides [207,212,213].
The de-epoxidation step has been considered to occur in the intestines prior to absorption but the
experimental evidence for this claim is weak as no de-epoxide metabolites were found in liver
homogenates nor in in vitro incubation with pig intestinal content from duodenum or jejunum [212].
However, de-epoxide metabolites were found in in vitro incubations with intestinal content of pig
caecum, rectum and colon [212].
It was previously reported that rumen microorganisms were capable of degrading NIV and
DON into their respective de-epoxide metabolites (Figure 10). In vitro rumen fermentation of DON
at concentrations equivalent to 5 ppm and 10 ppm in feed, showed about 89% of DON was reduced
within 48 h of incubation [81]. The study also reported that the amount of trichothecenes in the feed
can affect the rate of transformation such that when DON was incubated at concentrations equivalent
to 50 ppm and 100 ppm in feed, only 49% and 38% of DON was transformed respectively by rumen
microbes [81]. In vitro incubation of 2 ppm NIV and DON in rumen fluid collected from Swedish
Red and White cows for 48 h resulted in 82% of NIV and DON converted into de-epoxy NIV and
DOM-1 respectively [83]. Results also suggest that de-epoxidation reaction is relatively slow as only
35% of DON was found to be de-epoxidised after six hours of incubation [83]. An in vivo trial in which
lactating Holstein cows were fed naturally DON-contaminated corn showed DON to be metabolised
to DO -1 and the etabolite was found to be excreted in urine, plas a and ilk [82]. Other DON
etabolites were also identified fro studies involving orally ad inistered DON into sheep where
glucuronide conjugated DON, glucuronide conjugated DO -1 and sulfate conjugated DON were
detected in urine and bile [84]. Anaerobic in vitro incubation of 1000 ppm DON in rumen fluid collected
from cannulated cattle showed 35% of DON was de-epoxidised after 96 h [85].
A study using in vitro incubation of 100 ppm DON in cattle rumen fluid showed biotransformation
of DON into DOM-1 and resulted in the isolation of a bioactive microorganism, identified as an anaerobic
Gram-positive bacterium [214]. Further study of the bacterium indicated a new species within the
genus Eubacterium, designated Eubacterium strain BBSH 797 [215]. The isolated strain was further
developed into a commercial product for trichothecene detoxification in animal feed designed for
poultry and swine diets under the brand name Mycofix®. A odified in vitro test model with pig
intestine inoculated with Eubacterium strain BBSH 797 and incubated with DON showed formation
Toxins 2020, 12, 664 19 of 37
of DOM-1 [88]. Toxicity test showed that DOM-1 was 500 times less toxic than DON [88]. In vitro
incubation of BBSH 797 with type A trichothecenes, T-2 toxin and scirpentriol showed that T-2
toxins undergo both hydrolysis of the acetyl group and de-epoxidation into non-toxic T-2 metabolites
(Figure 11) while scirpentriol was de-epoxidised into non-toxic de-epoxy scirpentriol (Figure 12) [86].
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Aflatoxins are naturally occurring mycotoxins and potent carcinogens produced mainly by fungi of
the Aspergillus family. They are known to be main contaminants of a var ety of tropical an subtropical
ood and feed tuffs. Since the discovery of aflatoxins, many studies were done on their negative effects
in laboratory animals an livestock which includ effects on animal performance, toxin m tabolism
and carryov r of toxin residues to animal products [216]. Aflatoxins are difura ocou arin derivativ s
c nsisting of a few groups namely B1, B2, G1, G2, M1 and M2. Aflatoxin B1 (AFB1) is considered to be th
most common nd most toxic aflatoxin [217]. The maximum allowable level of AFB1 in food and feed
set by the European Commission regulation (EU) 1881/2006, amended by the European Co mission
regulation (EU) 165/2010 is 2 µg/kg [218]. AFB1 is known to be hepatotoxic and c rci ogenic [2 9,220],
nd also causes other negative effects that can be either directly or indirectly associated with the
toxicity such as immunosuppression, reduced feed utilisation, reduced animal productivity and growth
rat . Susceptibility o AFB1 v ries for every animal species with different acut toxic manifestations.
AFB1 hepatocarcinoge esis was reported in various anim l species where fish and poult y were found
to be extremely sensitive to AFB1 while mice and rats can tolerate higher concentrations of AFB1 b fore
showing hepatic tumours [219,221]. Cattle consuming a sufficient dose of aflatoxins can have negativ
affects to their health, performance a d reproduction [45]. Cattl affected by aflatoxicosis are reported
to suffer from adver e health effects which include weight loss, li er damage, d creased milk yield and
reduc d feed utilisation effici ncy [46].
Mec anisms of AFB1 absorption an etabolism were previous y studied and reported in both
an mals and humans [217,222,223]. AFB1 metabolism mainly happens in the liver but AFB1 can be
also m tabol ed in the kidneys as residues c n be detect d from urine. AFB1 can be m tabolised
by a range of cytochrome P450s which include CYP1A2, CYP3A4 a d CYP2A6 from the liver and
other tissues [217]. Cytochrome P450 enzymes (CYP450) in the liver metabolise AFB1 into aflatoxin M1
(AFM1), afla xin P1 (AFP1), aflatoxin Q1 (AFQ1) and aflatoxicol. The toxicity mechanism of AFB1
is described as below (Figure 13). AFB1 can be metabolis d to form ep xides AFB1-8,9-exo-epoxide
and AFB1-8,9-endo-epoxide in the e doplasmic reticulum. AFB1-8,9-exo-epoxide is h ghly unstable
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and reacts more readily with DNA to form AFB1-N7-guanine adducts by intercalation of epoxide
between base pairs which can induce cell mutations causing cancer compared to AFB1-8,9-endo-epoxide.
Similar to AFB1, metabolite AFM1 can be activated to form AFM1-8,9-epoxide and bind to DNA
forming AFM1-N7-guanine adducts. The epoxides are also able to bind with other macromolecules
such as protein to induce toxicity and be further metabolised into AFB1-N7-lysine adducts by the
formation of covalent bonds between the epoxide and serum albumin. Both guanine and lysine adducts
of AFB1 and AFM1 are found to be excreted in urine. AFP1, AFQ1 and aflatoxicol are excreted in urine
or in feces in the form of glucuronyl conjugates from bile. The epoxides can be also conjugated to form
GSH-conjugates which can be further detoxified by glutathione S-transferases. AFB1-8,9-epoxides can
be further hydrolysed to form AFB1-8,9-dihydrodiol which can also bind to proteins to form AFB1-lysine
adducts. Alternatively, AFB1 can be also hydroxylated via monooxygenases and also form glucuronide
and sulfate conjugates.
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With the wide-spread effects of AFB1 o a i al ealt a t e risk of ycotoxin contamination
in food r cts f r human consumption, it is not surprising that there are many studies being
d e on ways to control and detoxify mycotoxins. Cu rent strategies used to detoxify mycotoxins
include physical, chemical and biological met ods. Physical and ch mical detoxification met ods
such as thermal inactivation and addition of chemical absorbents in feed were found to be time
con uming, costly o on partially effective and not able to be upscaled for real-world application [ 24].
Adsorbent fe d additives such as cti t i alu iniu silicates at low
fe d inclusion rates wer not effective in binding afl toxins while these adsorbents, if used at high feed
inclusion rates, caus binding of essential nutrients [225]. Therefore, use of nzymes or microorganisms
has eme ed as an lternativ strategy o detoxify aflatoxins in an mals s they are considered to be an
effectiv and saf r detoxificatio metho .
AFB1 detoxification by rumen micro rganisms was among the arliest mycot xins reported to be
degraded in the rumen. Early studies on aflatoxin excr tion of sheep and cattle in Engla d that were
orally dosed with pure mixed aflatoxins B1, G1 and B2 reported that AFB1 levels in urine and faeces of
cattle were higher compared to sheep. The metabolite AFM1 which was excreted by cattle was only
4.09% of the AFB1 administered from the oral dose, while 3.55% of AFB1 was unmetabolised [226].
The result suggested that remaining AFB1 had undergone degradation to non-toxic metabolites.
The authors argued that the higher levels of AFB1 in urine and faeces of cattle than in sheep suggested
sheep rumen microbes may have greater AFB1 detoxification activity compared to cattle. Incubation of
AFB1 in vitro in rumen fluid of domesticated Holstein steers and native goats in Korea reported AFB1
degradation of about 14% and 25% in steers and goats respectively [227]. This study did not report the
identification of any rumen microorganisms nor detect any AFB1 metabolites.
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There are also studies reporting the isolation of bacterial strains capable of detoxifying AFB1.
Although the isolated bacteria were not of rumen origin, these bacteria could be potential probiotics
for ruminants which can be applied to AFB1 contaminated feed. Isolated Bacillus strains from Thai
fermented soybean product incubated in vitro with pure AFB1 showed the Bacillus strains were able
to degrade between 50% and 70% of AFB1 [228]. Degradation was observed to occur within the
first 5–6 days of incubation followed by AFB1 concentrations remaining constant until the end of the
incubation time [228]. A gut bacterium isolated from fish gut was found to be able to degrade 81.5%,
60% and 80.7% of AFB1, AFM1 and AFG1 respectively in vitro [229]. The microbe responsible for the
degradation was identified to be a strain of Bacillus subtilis [229]. Broilers that were fed a basal diet
containing AFB1 and a combination of the bacteria Lactobacillus casei, Bacillus subtilis and Pichia anomala
did not suffer negative effects of AFB1 on chicken’s production performance [230], and the authors
suggested AFB1 was successfully detoxified by the combination of these probiotics.
Degradation metabolites of AFB1 have been previously identified. AFB1 metabolites aflatoxicol,
aflatoxin B2a (AFB2a) and aflatoxin D1 (AFD1) are degradation products produced by Streptococcus spp.
and Lactobacillus spp. which are facultative anaerobes that can be present in the rumen (Figure 14) [87].
In vitro toxicity studies reported that these metabolites were found to be less toxic than AFB1.
Aflatoxicol was found to be 18 times less toxic compared to AFB1 but was able to form adducts with
DNA. AFB2a is 200 times less toxic than AFB1 and is considered to be relatively non-toxic. AFD1 was
found to be non-toxic based on in vitro toxicity studies using Hela cells [87,231,232].
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Ochratoxin A (OTA) is a mycotoxin produced by Aspergillus and Penicillium fungi and OTA is 
found to be a natural contaminant in foodstuffs of plant origin in tropical, subtropical and temperate 
regions [47]. In areas with cooler climates, OTA tends to be produced by Penicillium fungi while 
Aspergillus fungi tend to produce OTA in warmer climates [233]. The maximum allowable level of 
AFB1 in food and feed set by the European Commission regulation (EU) 1881/2006, amended by the 
European Commission regulation (EU) 594/2012 is 3 µg/kg [234]. OTA exposure in animals is shown 
to be mainly nephrotoxic showing other pathological responses which are hepatotoxic, teratogenic 
and carcinogenic [47,48]. Furthermore, OTA toxicity in animals can also cause potential indirect 
human exposure to OTA through animal derived food where trace OTA was detected in meat, milk, 
dairy products and other animal derived foodstuffs [235–237]. OTA is considered to be the cause for 
the Balkan endemic nephropathy which is a human kidney disease caused by tumours in the urinary 
tract leading to irreversible kidney damage [238]. In vitro and in vivo studies suggest that OTA 
exposure to animal/human cells, resulted in the overproduction of free radicals resulting in oxidative 
stress [51–53]. Studies showed that OTA is responsible for lipid peroxidation whereby OTA-Fe3+ 
complex was reduced to OTA-Fe2+ complex in the presence of NADPH-CYP450 reductase initiating 
the formation of free radicals [54,239]. OTA could induce DNA strand breaks and induce the 
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4.3. Ochratoxin A
Ochratoxin A (OTA) is a mycotoxin produced by Aspergillus and Penicillium fungi and OTA is
found to be a natural contaminant in foodstuffs of plant origin in tropical, subtropical and temperate
regions [47]. In areas with cooler climates, OTA tends to be produced by Penicillium fungi while
Aspergillus fungi tend to produce OTA in warmer climates [233]. The maximum allowable level of
AFB1 in food and feed set by the European Commission regulation (EU) 1881/2006, amended by
the European Commission regulation (EU) 594/2012 is 3 µg/kg [234]. OTA exposure in animals
is shown to be mainly nephrotoxic showing other pathological responses which are hepatotoxic,
teratogenic and carcinogenic [47,48]. Furthermore, OTA toxicity in animals can also cause potential
indirect human exposure to OTA through animal derived food where trace OTA was detected in
meat, milk, dairy products and other animal derived foodstuffs [235–237]. OTA is considered to be
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the cause for the Balkan endemic nephropathy which is a human kidney disease caused by tumours
in the urinary tract leading to irreversible kidney damage [238]. In vitro and in vivo studies suggest
that OTA exposure to animal/human cells, resulted in the overproduction of free radicals resulting
in oxidative stress [51–53]. Studies showed that OTA is responsible for lipid peroxidation whereby
OTA-Fe3+ complex was reduced to OTA-Fe2+ complex in the presence of NADPH-CYP450 reductase
initiating the formation of free radicals [54,239]. OTA could induce DNA strand breaks and induce the
production of oxidative chromatin and DNA damage in vitro, inhibiting the growth of umbilical cord
matrix mesenchymal stem cells [50,240]. The Phe moiety of OTA could compete with Phe for binding
to Phe-tRNA synthetase thus inhibiting peptide elongation [241].
The bioavailability of OTA varies depending on the food matrix. In vitro digestion model
studies suggest 30–100% of OTA to be bioavailable while some OTA that was not absorbed in the
upper gastrointestinal tract could travel down to the colon and be absorbed into the body [242,243].
OTA generally has a longer half-life in blood than in tissues due to the higher binding affinity of OTA
to blood proteins [244]. Animal studies also showed that OTA was found to be distributed mostly in
the kidneys follow by liver, muscle and fat consistent with OTA as nephrotoxic [47]. OTA metabolites
have been characterised in different species based on in vitro and in vivo studies. The major metabolic
pathway of OTA includes the toxin being biotransformed through hydrolysis, hydroxylation, opening of
the lactone ring and conjugation. OTA was shown to undergo hydroxylation by both phase I and
phase II CYP450 enzymes forming hydroxyl metabolites, (4R)-4-hydroxyochratoxin A ((4R)-OH-OTA),
(4S)-4-hydroxyochratoxin A ((4S)-OH-OTA), 5′-hydroxyochratoxin A, 7′-hydroxyochratoxin A and
10-hydroxyochratoxin A [47,245,246]. Oxidation of OTA by CYP1A1/1A2 and CYP3A1/3A2 by
rat liver microsomes also produced (4R)- and (4S)-OH-OTA [247]. CYP450 enzymes oxidise OTA
to produce OTA-quinone which could be further be conjugated with GSH or reduced to form
OTA-hydroquinone [248]. OTA can be biotransformed to ochratoxin B which is a dechlorinated form
of OTA by renal microsomes [49]. OTA metabolites were found to be less toxic than OTA however
their toxic effect is still strong enough to induce OTA toxicity [47,249].
OTA residues can be found in animal tissues which include the muscles, liver, kidney and
serum [250]. OTA feed contamination causes nephropathy in pigs with observed progressive interstitial
fibrosis and regressive tubular changes with thickening of the basement membrane in the porcine
kidney [251]. Chickens fed with OTA were observed to have swollen kidneys, yellowish livers,
hyperplasia of the binary epithelium and hypertrophy of renal proximal tubular epithelial cells [252].
Ruminants on the other hand are rarely reported to be acutely susceptible to OTA while the harmful
effects of OTA are usually due to the prolonged ingestion of the toxin instead [250]. However, OTA was
found to be absorbed relatively quickly into the bloodstream of ruminants which could be of health
concern for ruminants due to accumulation of OTA in the bloodstream [250]. Despite ruminants being
reported as more resistant to OTA poisoning, there are still some reports on ochratoxicosis in ruminants.
Ewes fed with OTA through intravenous infusion died within 24 h [55]. Goats that were fed with daily
oral doses of OTA at 3 mg/kg bw were reported to have died within five days of feeding [56].
The chemical structure of OTA consists of a dihydroisocoumarin named ochratoxin α (OTα) which
is linked through a C9 carboxyl group (attached at C7), to L-α-phenylalanine by an amide bond [47].
Non-ruminants are found to be more susceptible to OTA while ruminants are relatively resistant to
OTA due to their ability to detoxify OTA [253]. OTA absorbs readily to the gastrointestinal tract of
monogastrics with little or no degradation, while OTA in ruminants undergoes microbial degradation
in the rumen before absorption into the bloodstream [48]. The most common microbial degradation
of OTA is the hydrolysis of the amide bond of OTA releasing the non-toxic OTα and phenylalanine
(Figure 15). Anaerobic microorganisms in the large intestine and cecum of monogastrics [254] and
in the rumen are found to be responsible for the degradation. Ruminants are considered to be less
susceptible to OTA compared to monogastric animals as the hydrolysis of OTα in rumen can occur
before absorption and is considered the principal OTA detoxification method in ruminants [255].
OTA that was administered into calves through a stomach tube resulted in death within 24 h supporting
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the claim that the rumen is responsible for OTA degradation [56]. Furthermore, pre-ruminant calves
were also observed to be susceptible to OTA with the calves dying within the first 24 h of dosing with
OTA [255].Toxins 2020, 12, x FOR PEER REVIEW 23 of 37 
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the isolate was not of rumen origin [228]. In vitro degradation studies using rumen fluid incubated
with OTA, followed by enrichment and culture dilution, isolated a rumen bacterium capable of cleaving
OTA into OTα and phenylalanine while partial 16S rRNA gene sequence analysis of the bacterium
showed that it is closely related to Lactobacillus vitulinus [88]. Different feed types are found to influence
OTA degradability in ruminal fluid. A study reported that OTA degradation was higher in ruminal
contents of sheep fed with hay compared to sheep that was fed with cereal [256]. Overall, the studies
suggest that high forage diets favour microbial populations in the rumen capable of OTA degradation.
4.4. Fumonisins
Fumonisins are a group of mycotoxins produced commonly by Fusarium verticillioides and
F. proliferatum which contaminate cereal grains. High levels of fumonisins in contaminated crops are
found to commonly occur in locations with warmer climates especially during drought seasons when
crop plants undergo heat stress [257]. Fumonisins are classified in four groups which are A, B, C and P
however only fumonisins of group A (A1 and A2) and group B (B1, B2 and B3) are commonly discussed
and studied [258]. Fumonisin B1 (Figure 16) is the most commonly studied fumonisin and has been
linked to leukoencephalomalacia in horses, pulmonary oedema in swine and hepatocarcinoma in
rats [259]. The maximum sum allowable levels of fumonisin B1 and fumonisin B2 in food and feed
set by the European Commission regulation (EU) 1881/2006 is 4000 µg/kg [260]. Epidemiological
studies linked fumonisin B1 to oesophageal cancer in humans [261]. Fumonisins are structurally
similar to sphingoid bases of sphinganine and sphingosine by possessing an unsubstituted primary
amino group at C2 which competitively inhibits ceramide synthase thus disrupting the synthesis of
ceramide and the metabolism of spingolipids [262]. This leads to the accumulation of sphinganine and
sphingosine in the liver and kidney cells causing metabolic effects such as mitochondrial apoptosis,
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impaired sphingolipids involved in synthesis and transport, degeneration of sphingolipid-rich tissues
and increasing oxidative stress and lipid peroxidation [258].Toxins 2020, 12, x FOR PEER REVIEW 24 of 37 
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Toxicological and pathological effects of fumonisins in animals are well documented [258,259].
Pharmacokinetic studies on rodents and primates showed that ingested fumonisins were absorbed
in the gastrointestinal tract, rapidly distributed in blood and accumulated mostly in liver and
kidneys [259]. Fumonisin toxicity was found to be dependent on sex, genus and dose-response
differences in animals. Female mice were found to be more susceptible to nephrotoxicity compared to
male mice [263] while rabbits were more sensitive to the toxic effects of fumonisin B1 compared to
rats [259]. Horses are the most susceptible to fumonisins with leukoencephalomalacia being a disease
of the nervous system causing necrosis, softening, cavitation and yellow discolouration in the grey
and white matter of the cerebral hemispheres [264]. Clinical symptoms in affected horses include
muscle weakness, blindness, heart weakness, coma and death in severe cases [264]. Onset of toxicity
occurs when horses consume 10 ppm fumonisin contaminated feed with symptoms showing within
7–180 days [265]. Consumption of 92 ppm fumonisin B1 in contaminated feed by pigs, caused death
within 48 h of ingestion [258]. Poultry are less sensitive to fumonisins where those with diets containing
100–400 mg/kg of fumonisins B1 showed liver necrosis, biliary hyperplasia and heart damage [266].
Ruminants are reported to be tolerant towards fumonisins although there are reports that ruminants
can develop toxicosis when fed with high concentrations of fumonisins. Fumonisin contaminated
feed up to 148 ppm caused mild liver lesions in feeder calves and lymphocyte blastogenesis [57].
Holstein milk-fed calves fed with 1 mg/kg bw of fumonisin B1 for seven days showed hepatic and
renal damage but cardiovascular function remained unaffected [58]. Oral feeding of fumonisins
from F. verticilloides cultures to lambs and goat kids also resulted in similar mild hepatic and renal
damage [59,60]. Ruminant resistance to fumonisins at low concentrations suggested the possibility that
rumen microorganisms may be able to metabolise fumonisins. Reports on fumonisin B1 degradation
by rumen contents are inconsistent. Studies of incubation of fumonisin B1 in rumen fluid of cattle for
72 h only showed up to 18% degradation with no metabolites detected [93]. In vitro incubation of
fumonisin B1 at varying concentrations (50 ppm and 100 ppm) for 72 h resulted in only 10% degradation
irrespective of fumonisin B1 concentration [94]. Another study reported that fumonisins incubated in
cattle rumen fluid at concentration of 100 ppm and 200 ppm showed no effect on volatile fatty acid
(VFA) production but decreased branched chain VFAs and ammonia concentrations were observed,
indicating the possibility of a shift in rumen bacterial populations in the presence of fumonisins [267].
No metabolites of fumonisin B1 were identified from these studies and the fumonisin concentration
used in the studies were high enough to induce toxicosis.
5. Conclusions
This review has highlighted the potential use of rumen microbial metabolism of natural toxins to
improve ruminant health and welfare. Rumen microorganisms have been shown to have the ability to
metabolise and detoxify a wide range of plant toxins and mycotoxins. Feeding a toxin to ruminants
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in low doses for a prolonged period of time has also demonstrated the potential to stimulate a shift
in rumen microbial populations to utilise a toxin. It has been also shown that some toxins can be
rendered non-toxic by a simple hydrolysis step using a rumen bacterium while other toxin metabolites
may require multiple metabolic reactions involving various rumen microorganisms for detoxification.
Inoculation of rumen contents of ruminants that are resistant to a certain toxin into naïve ruminants
has been shown to transfer toxin resistance. Further work is however required to understand the effect
of rumen microbial population shifts on the metabolic activity in the rumen. There is also the need to
identify rumen microorganisms responsible for detoxification and to investigate the metabolic pathways
of detoxification. Toxin metabolites also need to be studied to determine their toxicity and chemical
structure to further understand the mechanism of action of the toxin. A complete understanding of
the detoxification by candidate rumen microorganisms would lead to the development of safe and
effective probiotics for ruminants. The number and diversity of toxin candidates presented in this
review highlights the potential to extend this approach to other toxins for which the capacity for
rumen microbial detoxification has not yet been explored. The review also shows the commercial
potential of rumen inoculum derived probiotics as safe and viable alternatives to improve ruminant
health and production while being cost-effective and timesaving compared to other conventional toxin
management strategies such as chemical detoxification and pasture management.
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